Abstract: The Electron Beam CT (EBT) Coronary Calcium Score (CCS) is an independent predictor of coronary events and adds incremental information to standard risk factors. How to use this information was uncertain. To assist our referring physicians in utilizing this test, a web based calculator was created that combines the Framingham score risk with the EBT CCS risk to obtain a new risk for cardiac events. To create this calculator, CCS breakpoints of 0, 80, 400, and 600 were selected; and from these breakpoints, 5 ranges of calcium scores: 0, 1-80, 81-400, 401-600, and >600 were defined. Bayes theorem was used to derive equations for the combined Framingham score risk and calcium score range risk for each CCS range. The sensitivity and specificity of each of these CCS breakpoints for the prediction of events was derived from prospective studies. These equations were then translated into a JavaScript program that could be accessed from a web browser. This calculator can be easily used to restratify many individuals classified as low, intermediate, or even high risk according to the Framingham risk score system into a different risk group, allowing more appropriate matching of intervention intensity with absolute cardiovascular event risk.
D
etermination of primary preventative therapy for cardiovascular disease is dependent on an assignment of absolute risk for coronary events. Currently, the Framingham risk scoring system 1 is the most widely accepted system in the U.S. for primary risk assessment. This system utilizes age, sex, smoking status, blood pressure, and cholesterol to assign a 10 years risk of coronary events. While accurate from a population perspective, making individual recommendations based on the Framingham risk score too often leads to incorrect decision making because half of all events occur in the individuals classified as low risk and, conversely, some individuals classified as high risk may be treated unnecessarily.
Many studies [2] [3] [4] using multivariate analysis have demonstrated that the electron beam CT (EBT) coronary calcium score (CCS) is an independent predictor of cardiac events and that event rates rise as the CCS rises for all calcium score ranges. The consensus findings from these studies is that individuals without detectable coronary calcium on EBT scanning are at very low risk for cardiac events and do not require primary prevention whereas individuals with the highest amounts of coronary calcium have greatly increased coronary event risk and require intensive intervention. 5 This leaves the individuals with the intermediate coronary calcium scores, for whom there is uncertainty in risk assessment. Clearly there is increased event risk in these individuals, but the question remains: Is this new risk sufficient to warrant an intervention?
One way to answer this question is to combine the global risk determined from the Framingham equations with the relative risk derived from the EBT CCS. The summary statement from the Prevention V Conference of the AHA 6 stressed the need to integrate CCSs with other risk factors. The participants of this conference were concerned that indiscriminate ''coronary calcium screening'' by itself could lead to inappropriate matching of intervention intensity with absolute cardiovascular event risk. The new question is then: How is the recombination of the risks from the Framingham score and EBT CCS to best be accomplished?
Because the primary determinates of cardiovascular event risk are age and sex, other authors 7, 8 have proposed the adoption of a system in which an ''arterial age'' determined from the CCS either adjusts or replaces the chronological age in a modified Framingham scoring system. The rational is that the rising event risk associated with increasing age is largely due to the development and progression of atherosclerosis. Because EBT coronary calcium scoring directly measures atherosclerotic burden, 9 it is proposed that it can be used to correct the chronological age to the ''arterial age of the heart,'' providing a more accurate assessment of risk. In practice, the patient's CCS is first compared with an index of scores standardized for age and sex and a ''corrected age'' is chosen so that the mean calcium score for that age matches the patient's calcium score. Experience at our center has found this system to be unwieldy and confusing to both the patient and our referring physicians. To illustrate, in this system, a 54-year-old woman is told her CCS of 81 places her in the 75th percentile for her age and sex and that her equivalent heart age is 65 years. Clearly, both the patient and the referring physician understand that this is not good, but beyond that confusion follows.
This article describes the creation of a web based calculator that combines the EBT calcium score risk with the Framingham score risk through the application of Bayes' theorem. This calculator can now be accessed through the internet at http://www.NewportBodyScan. com/InformationforPhysician's.htm. This project involved several stages. In the first stage, Bayes' theorem was used to derive the necessary equations. In the second stage, the literature was reviewed to determine the values of the sensitivities and specificities of the CCS for the prediction of 10 year events. Finally, a JavaScript application was developed to execute these functions, and the results were then tuned so that the calculated CAC range relative risk ratios matched the observed relative risk ratios.
DEVELOPING RISK RANGE EQUATIONS
The first step was the selection of appropriate calcium score ranges. The 0 score, being a negative test, was the starting point. According to the original data from Arad et al, 10 a CCS of 80 appeared to maximize the value of both the sensitivity and specificity of the calcium score for the prediction of events, and so a score of 80 was chosen to be the second break point. To separate out the individuals with very high scores, scores of 400 and 600 were chosen to be the final breakpoints. This defines 5 ranges of calcium scores: 0, 1-80, 81-400, 401-600, and greater than 600. The derivation of the range risk using Bayes' theorem is detailed in Appendix A. If ''R'' is the Framingham 10 years event global risk, the formulas for the combination of risk ''R'' with each EBT CCS range risk are:
DETERMINATION OF THE SENSITIVITIES AND SPECIFICITIES
Sensitivities and specificities for each of the EBT CCS values of interest (Table 1) for the prediction events were derived from the most recent prospective studies of Kondos et al 11 (0) and Arad et al 12 (80, 400, and 600) (detailed in Appendix B). Because neither of these studies had a duration of 120 months, a correction was introduced using the assumption that the event rates would remain constant if the observation period had been allowed to continue on out to 120 months.
JAVA SCRIPT
A JavaScript application was then written to execute these functions. The code is detailed in Appendix C. Initial testing discovered that predicted range risks relative to a CCS of 0 were 6, 24, 44, and 81 for CCS ranges of 1-80, 81-400, 401-600, and >600. These numbers are greatly in excess of the established relative risk ratios for these calcium score ranges. A meta-analysis on coronary calcium and 32 to 43 month event risk 4 using fixed-effects modeling and subgroup analysis found mean adjusted risks relative to a CCS of 0 were 2.6, 8.8, and 17 for CCS ranges of 1-100, 101-400, and greater than 400. Arad et al 11 's most recent report on 4613 asymptomatic persons aged 50-70 followed for 4.3 years found relative CCS range risks of 1.9, 10.2, and 26.2 for these same CCS ranges. The explanation for the exaggerated risk range ratios appears to be the compounding effect of information overlap. Because both Framingham risk and CCS increase with age and male sex, the effect of combining these non-independent risk factors amplifies the new risk.
To compensate for the effect of information overlap between the Framingham calculation and the CAC score, a linear correction factor was introduced. The thinking is as follows: if the information overlap is 100%, then the combined risk would be identical to either individual risk alone; whereas, if there is no information overlap, then the combined risk will be the Baysean combined risk. So a formula that corrects the risk would look like: Rcorr = aR(Framinham)+bR(combined risk) where a+b = 1. Because both Framingham risk and CAC increase with age and sex, when either is low, the information overlap would be expected to be low; information overlap increases as both Framingham risk score and CAC score increase. After some trial and error, it turned out that an ''a'' value of about 0.40 for the highest Framingham risk and CAC scores was sufficient to bring the relative CAC range score risks down to the observed relative risk 
COMMENT
Of all the diagnostic tests in medicine, the coronary calcium score was uniquely suited for this analysis because of the dichotomy of extremely high sensitivity but low specificity for the presence of any coronary calcium and the low sensitivity but very high specificity when coronary calcium scores are very high. The main result of these calculations is that individuals without detectable coronary calcium are at extremely low risk for events, whereas the majority of the risk is incurred by individuals with very high calcium scores. This is in concordance with the statements of the ACC/AHA expert consensus document on EBT 13 : ''A negative test may be consistent with a low risk of cardiovascular event in the next 2 to 5 years'' and ''A high calcium score may be consistent with moderate to high risk of a cardiovascular event within the next 2 to 5 years.'' Raggi et al 14 followed 632 asymptomatic individuals for 32 ± 7 months for the occurrence of MI's or death. Individuals without detectable coronary calcium had an annual event rate of 0.11%, whereas annual event rates were 4.8% when the CCS was above 400. A recent prospective study 15 of 5585 subjects aged 59.5 ± 5 years followed for a mean of 52.6 months found the negative predictive power of a calcium score below 100 was 99.2%. This calculator provides clinicians with an easy tool for incorporating the EBT CCS into routine clinical practice to weed out individuals who are at low risk for events, allowing risk-reduction therapy to be targeted to smaller but higher-risk populations.
This analysis was performed on data collected predominantly from men. This leads to the question: How valid are these results for women? While it is not possible to address that particular question because of the limited data, the converse ''Why should these results not be valid for women?'' is approachable. Although the onset of atherosclerosis is delayed in women by an average of 10 years, there is no evidence that progression of the disease or the development of coronary calcium differs in men and women. 16 On the average, women do have smaller hearts and narrower coronary arteries then men so it would not be unexpected to find that calcium deposits might also be smaller, 17 and so the CCS breakpoints may need to be lowered in women. Indeed, although Budoff et al 18 reported no sex differences in the sensitivity of coronary calcium for the presence of obstructive disease in women, they did find that absolute CCS values in women lagged men by an average of 14.5 years, even though events only lag by 10 years 19 and, more interestingly, in that study a CCS of 34 was found to maximize both the sensitivity and specificity for the prediction of obstructive CAD in women at 81% according to the receiver operating characteristic curve. More observational data on CCS in women and event rates is clearly needed.
Since posting this calculator (Fig. 1) , our weblogs indicate that the webpage www.NewportBodyScan.com/ CACrisk.htm is currently being accessed about 10 times each day or 300 times each month, and the feedback from our referring physicians has been very positive. 
Sensitivity (Se) is defined as the ratio TP/(TP+FN) Specificity (Sp) is defined as the ratio TN/(TN+FP)
Bayes' equations are shown below: Probability of an event given a positive test = ðTPÞ ðTPÞ þ ðFPÞ Â 100
Probability of an event given a negative test = ðFNÞ ðFNÞ þ ðTNÞ Â 100
Now consider a nonzero calcium score; by definition, the following matrix is created:
And for a calcium score greater than 80, the matrix becomes:
A new matrix that combines these 2 scores into a single, 3 column matrix must look like this:
So how do we determine what the unknown factors ''a'' and ''b'' are for the middle column of the matrix? For that we use the boundary condition that the event rate in the top row has to sum to ''R'' and the no event rate in the bottom row has to sum to ''100 À R''.
And ð100 À RÞ ¼ ð100 À RÞð1 À Sp80Þ þ ðð100 À RÞ Â bÞ þ ðð100 À RÞ Â Sp0Þ Solving for b gives: b = Sp80 À Sp0. So the 3 column matrix for 2 calcium scores is:
Generalizing this result to 4 calcium scores, the 5 column range matrix shown in Table AA1 was created. Note that the total event rate in the top row sums to R; whereas in the bottom row, the total no event rate sums to (100 À R).
Then, according to Bayes' Theorem, the formula for the combined risk R and CCS range risk is the ratio of events in the CCS range of interest to the total of events and nonevents in that CCS range. If ''R'' is pretest risk, the formulas for the new combination of risk ''R'' with each CCS range risk are:
APPENDIX B: DETERMINATION OF THE SENSITIVITIES AND SPECIFICITIES
Currently, there are 2 prospective studies large enough and of sufficient duration to provide data for the values of the sensitivities and specificities of the EBT CCS of interest for the prediction events. These are the studies of Kondos et al 11 and Arad et al. 12 These studies are also complementary in that Kondo's study looked at the effect of either the presence or absence of coronary calcium on events, whereas Arad's study focused on the effect of increasing EBT CCS on event risk. Starting with the work of Kondos et al, 11 this study reported 37 month follow-up data from 4151 men and 1484 women, mean age 52 years, without known coronary disease, who were either self or physician referred for a screening EBT examination. 191 events were seen in the male population, but only 32 events were observed in the female population. Because so few events occurred in the female population, this group is excluded from this analysis. The 37 month matrix for the distribution of events and the presence of coronary calcium for asymptomatic men is detailed below: This matrix gives a sensitivity of 98% and a specificity of 27%. To estimate the effect of adding additional observation time, the assumption was made that event rates will remain constant, so the total events expected after 10 years (120 months) will be (120/37) Â (the 37 month event total) = 619. According to this constraint, the revised matrix of the distribution of events and the presence of CAC after 120 months becomes: for a corrected sensitivity and specificity for a CCS greater than 0 of 98% and 30%.
Arad et al 12 observed 4613 asymptomatic individuals, mean age 53 years, 71% male, for an average of 4.3 years following EBT CCS and plotted sensitivity and specificity versus the square of the CCS. From the published figure, the sensitivity and specificity of an EBT CCS of 80 for the prediction events was read off as 81% and 68%, for CCS of 400: 35% and 95%, and for CCS of 600 the numbers were 25% and 97%.
To correct these numbers to 10 years (120 months), an event incidence of 5% (events = 100, no events = 1900) was assumed to create the initial matrix. Starting with a CCS of >80: sensitivity 82%, specificity 68%, the 51.6 month matrix is: Event rate (R) R Â Se600 R(Se400 À Se600) R(Se80 À Se400) R(Se0 À Se80) R(1 À Se0) No event rate (100 À R) (100 À R)(1 À Sp600) (100 À R)(Sp600 À Sp400) (100 À R)(Sp400 À Sp80) (100 À R)(Sp80 À Sp0) (100 À R)Sp0
